Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5269181
Chembl Id: CHEMBL5269181
Max Phase: Preclinical
Molecular Formula: C35H41F3N6O5S
Molecular Weight: 714.81
Associated Items:
ID: ALA5269181
Chembl Id: CHEMBL5269181
Max Phase: Preclinical
Molecular Formula: C35H41F3N6O5S
Molecular Weight: 714.81
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(N)nc3c2ncn3C(=O)Nc2cccc(C(F)(F)F)c2)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C35H41F3N6O5S/c1-6-32(4)15-23(33(5)18(2)10-12-34(19(3)27(32)47)13-11-22(45)26(33)34)49-24(46)16-50-29-25-28(42-30(39)43-29)44(17-40-25)31(48)41-21-9-7-8-20(14-21)35(36,37)38/h6-9,14,17-19,23,26-27,47H,1,10-13,15-16H2,2-5H3,(H,41,48)(H2,39,42,43)/t18-,19+,23-,26?,27+,32-,33+,34+/m1/s1
Standard InChI Key: XBPFUVJYTJNTHN-JATDXGTRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 714.81 | Molecular Weight (Monoisotopic): 714.2811 | AlogP: 6.51 | #Rotatable Bonds: 6 |
Polar Surface Area: 162.32 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.79 | CX Basic pKa: 1.51 | CX LogP: 5.69 | CX LogD: 5.69 |
Aromatic Rings: 3 | Heavy Atoms: 50 | QED Weighted: 0.11 | Np Likeness Score: 0.32 |
1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y.. (2023) Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives., 14 (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004] |
Source(1):